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ABSTRACT 
Association of atherosclerosis and coronary artery disease well known main pathophysiologic basis for 
Ischemic Heart Diseases and Myocardial Infarction and due to major risk factors such as high plasma level 
of low density lipoprotein, low plasma level of high density lipoprotein, cigarette smoking, hypertension 
and diabetes mellitus, infection with few infectious agents such as Mycoplasma pneumoniae that might 
associated with atherosclerosis consider as another risk factor for ischemic heart diseases. Aim of this 
study is to investigate the role of this organism and its association to the risk of exposure to Mycoplasma 
pneumonia infection for ischemic heart diseases in Saudi population. This was a case-control study in 
which 96 patients studied and they  were in two  groups:  first  group (or case  group), include 48  units 
patients who had been admitted in hospital by diagnosis of Ischemic Heart Diseases including Unstable 
angina and Myocardial Infarction (STEMI, NSTEMI) and second group (or control group), include 48 
healthy  units patients  who  had no modifiable risk  factors history of Ischemic Heart  Disease and they 
matched by first group, for age index. IgG antibodies to Mycoplasma pneumoniae was assessed by ELISA 
technique in both groups. In the case group, 15 cases out of 48 and in control group 3 out 48 were positive 
for  antimycoplasma  antibody  and  in  both  groups.  There  was  significant  statistic  difference  in 
antimycoplasma antibody level. In the groups (p = 0.004) and the relative risk of mycoplasma infection for 
Ischemic heart diseases estimated to be 5. It seems that Mycoplasm pneumoniae infection is a risk factor 
for Ischemic Heart Disease, in Saudi population. This is the first report study of such a disease in Saudi 
Arabia.Further  studies  will  needed to evalute the risk of  coinfection by Mycoplasma  pneumoniae and 
Chlamydia pneumoniae and also better to evalute the effects of the risk of these infection and conventional 
risk factors for Ischemic Heart Disease in this country. 
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1. INTRODUCTION 
  Ischemic Heart Diseases (IHD) is a coronary artery 
disease which is a well-established major cause of death 
and  disability  in  both  developed  and  developing 
countries  (Backer,  2009).  In  United  States,  Twelve 
million  individuals  in  the  United  States  and  143 
million  worldwide  have  Coronary  Artery  Disease 
(CAD) (Selwyn and Braunwald, 2005). Regardless of 
declines in developed countries, both CAD mortality Osama M.S. Abdul-Wahab et al. / American Journal of Immunology, 8 (4) (2012) 117-122 
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and the prevalence of CAD risk factors continue to rise 
rapidly in developing countries (Spence et al., 1999). 
  In this country, Cardiovascular Disease (CVD) and 
Coronary  Heart  Disease  (CHD)  are  major  health 
problems. The most recent WHO statistics for Saudi 
Arabia have reported a total death rate of 156.87 per 
100,000  persons  (36%)  death  from  CVD,  with 
diabetes being responsible for a further 5% of deaths 
(Rawas et al., 2012). 
  As it was clearly known the main pathophysiologic 
bases  for  IHD  and  Mycocardial  Infarction  (MI)  is 
(CAD) that causes reduction in oxygen supply to cardiac 
tissue  which  leads  to  clinical  manifestations  of 
myocardial  ischemia  (Selwyn  and  Braunwald,  2005). 
Furthermore, the most common causes of the CAD is 
atherosclerosis  with  major  risk  factors  including  high 
plasma  level  of  Low  Density  Lipoprotein  (LDL),  low 
plasma  level  of  High  Density  Lipoprotein  (HDL), 
cigarette  smoking,  hypertension  and  diabetes  mellitus 
(Selwyn and Braunwald, 2005). 
  Beside  the  well-established  conventional  risk 
factors for atherosclerosis, studies have suggested that 
infection  with  Chlamydophila  pneumoniae, 
Helicobacter pylori and Cytomegalovirus can initiate or 
maintain  the  atherosclerotic  process  (Danesh,  1999; 
Fong, 2000; Awadalla et al., 2011). 
  In  recent  studies,  there  is  data  in  literature 
concerning  the  association  between  IHD  and 
Mycocardial  infarction  with  Mycoplasma  pneumonia, 
another atypical bacterium which might associate with 
atherosclerosis either alone or coexistence with other 
conventional  risk  factors  (Momiyama  et  al.,  2004; 
Goyal  et  al.,  2007;  Pourahmad  et  al.,  2009). 
Mycoplasma  pneumoniae  which  is  the  smallest  and 
simplest self-replicating microorganism, can exist as a 
persistent  asymptomatic  infection,  resulting  in  chronic 
inflammation  as  well  as  Chlamydia  pneumonia   
(Waiters  and  Talkington,  2004;  Waites  et  al.,  2008). 
This pathogen is out of 17 known human mycoplasmas 
species, is a significant respiratory pathogen in persons 
of  all  ages,  causing  respiratory  diseases  and  it  may 
induce  clinically  significant  manifestations  in  extra-
pulmonary sites by direct invasion and/or immunologic 
effects.Macrophage  activation,cytokine  induction  and 
super-antigen properties are some factors related to the 
pathogenicity  of  mycoplasmas  (Razin  et  al.,  1998; 
Waiters and Talkington, 2004; Waites et al., 2008). 
  In Saudi Arabia, To our knowledge there has been 
no  previous  and  information  studies  about  of  the 
association of exposure to M. pneumoniae with IHD and 
its  complications  and  there  is  lack  of  national  data 
available from community based on the prevalence of 
CAD in this country (Al-Nozha et al., 2004) and in a 
study it found the overall prevalence of CAD was 5.5% 
from a patients with statistically significant modifiable 
risk factors (Al-Nozha et al., 2004).  
  Therefore  it  is  important  to  investigate  the 
possible  risk  and  relation  of  exposure  toM. 
pneumonia  infection  for  CAD  and  MI  so  we 
conducted  this  study  to  recognize  the  role  of  this 
organism and its association to the risk exposure to 
(IHD) in Abha (a city in southwest region of Saudi 
Arabia) among Saudi population. 
2. MATERIALS AND METHODS 
  This is a case-control study, in which 96 patients 
studied. The study conducted during one year (March, 
2011-FEB, 2012) in Cardiologic ward at Asser Central 
Hospital  in  Abha  (a  cityin  southwest  region  of  Saudi 
arabia).  The  units  selected  by  simple  nonrandomized 
sampling  technique.  They  were  in  two  groups:  first 
group (or case group), include 48 units who had been 
admitted  in  hospital  by  diagnosis  of  acute  Coronary 
Syndrome (IHD) such as unstable ungina, Myocardial 
Infarction  (STEMI,  NSTEMI)  and  second  group  (or 
control group) include 48 healthy units who had not any 
positive history of IHD and they matched by first group, 
for  age  index.  Inclusion  Criteria  in  first  group  were: 
Typical Chest pain for IHD, positive Electrocardiogram 
(ECG)  and  serum  biomarkers  for  myocardial 
infarctiIon.Upon ECG signs; the case group was divided 
into  two  groups:  ST  elevated  and  NonST  elevated 
myocardial  infarction  (STEM  and  NSTEMI 
respectively) (Antman and Braunwald, 2005). 
  Exclusion criteria for two groups were: Two blood 
pressure recordings of 140/90 mm Hg or higher, fasting 
blood glucose level more than 110 mg dL
-1, serum total 
cholesterol  level  more  than  200  mg  dL
-1,  history  of 
smoking and family history of coronary artery disease. 
  In  all  units  (cases  and  controls)  a  fasting  blood 
sample  (3  mL)  collected  for  analysis  for  serologic 
markers of M. pneumoniae. 
  IgG antibodies to M. pneumoniae were assessed by 
ELISA  technique;  Vircell  Microbiologists  kit  for 
Mycoplasma was used for detection of IgG antibodies to 
M. pneumoniae and a sample with antibody index value 
of more than 11 was considered seropositive as having Osama M.S. Abdul-Wahab et al. / American Journal of Immunology, 8 (4) (2012) 117-122 
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IgG  specific  antibodies  against  M  pneumonia  on 
manufacturer's guidelines vircel microbiologists. 
  All  our  information  was  Statistically  analyzed  by 
using  the  Statistical  Package  for  the  Social  Sciences 
version 13.0 (SPSS software, Inc., Chicago, IL, USA). 
SPSS software and for statistic analysis, t-test and chi 
square test was used. Results with P value less than 0.05 
was considered as statistically significant. 
3. RESULTS 
  Ninety six 96 patients were studied. Mean age of 
the  patients  in  case  group  was  62.54±11.19  and  in 
control  group  was  64.68±13.65.There  was  not 
significant  statistic  difference  for  age  between  two 
groups (p = 0.26) Fig. 1. 
 
 
 
Fig. 1. Age wise distribution of Patients in case group (n = 48) 
 
Table 1: Antimycoplasma antibody in case and control groups (n = 48; 
n = 48) 
  Antimycoplasma ab 
  ------------------------------------------------------------------- 
Group  Positive  Negative  Total 
Case  15  33  48 
Control  3  45  48 
P = 0.004 
 
Table 2: Antimycoplasma antibody in STEMI, NSTEMI and Unstable 
angina 
  Antimycoplasma ab 
  ----------------------------------------------------------- 
MI type  Positive (%)  Negative (%)  Total 
STEMI  10 (40)  15 (60)  25 
NSTEMI  1(8.3)  11(91.6)  12 
Unstable angina  4(36.3)  7 (63.6)  11 
Total  15  33  48 
P = 0.138 
  In  case  group  (patients  with  diagnosis  of  acute 
Coronary  Syndrome  (IHD)  such  as  unstable  ungina, 
Myocardial Infarction -STEMI, NSTEMI) 15 cases out 
of 48 and in second group (control group) 3 units out of 
48 were positive for antimycoplasma antibody and this 
difference  was  statistically  significant  (p  =  0.004) 
(Table 1). The relative risk of antimycoplasma antibody 
for myocardial infarction in our patients. OR = 5(95% 
C.I = 1.54-16.16). 
   Fasting blood glucose and serum total cholesterol 
levels  in  both  case  and  contro  lgroups  were  within 
normal limits. 
  In  this study  from  48  patients  with  Myocardial 
Infarction, 25(52%) patients had STEMI and 12(25%) 
patients  had  NSTEMI,  11(23%) patients  had  Unstable 
angina;  10,  1,4  patients had  positive antimycoplasma 
antibody  in  STEMI,  NSTEMI  and  Unstable  angina 
groups  respectively,  but  the  difference  was  not 
statistically significant (p = 0.138) (Table 2).  
4. DISCUSSION 
   Many  studies  are  conducted  to  evaluate  the  risk-
factor  for  IHD  and  MI  in  populations,  some  of  these 
studies designed to evaluate the other than risk factors 
for IM, among these factor is infection as risk factor that 
need  further  investigation  and  for  this  purpose  we 
conducted this study to recognize the role of infectious 
agent and its association to the risk exposure to (IHD). 
  On the other hand, other studies have reported the 
relation  between  infections  such  as  Mycoplasma 
pneumoniae and Chlamydia pneumoniae a with IHD and 
MI and they evaluate the effect of these infectious agents 
in CAD, however, few studies will contribute to evaluate 
the relative risk of these agents with IHD and MI.  
  In the present study Mycoplasma pneumonia the 
Odd’s ratio for Mycoplasma pneumonia infection in 
our patients with MI was revealed that the infection 
with this agent might be a risk factor for IHD and MI 
(OR = 5.00). 
  A  similar  study  was  conducted  in  Iran,  in  which 
seropositivity  to  Mycoplasma  pneumonia  was 
significantly higher (p<0.05) in CAD patients with MI 
than in those without MI and the risks (Odd’s ratio0 
of  this  infection  has  been  accounted  to  be  2.7 
(Pourahmad et al., 2009), although patients studied were 
of both sex, there was no significant statistic difference 
in sex proportion in the studied groups (p = 0.26). In 
another previous study, conducted in patients of same Osama M.S. Abdul-Wahab et al. / American Journal of Immunology, 8 (4) (2012) 117-122 
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contrary;  the  relative  risk  of  Chlamydia  pneumonia 
infection  for  MI  (OR  =  2.3)  (Pourahmad,  2005)  was 
lower than that for Mycoplasma pneumonia. 
  In another study conducted in Japan, Mycoplasma 
pneumonia seropositivity was more prevalent in patients 
with CAD than without CAD (14% versus 6%, p<0.01). 
The highest prevalence was found in patients with MI. In 
contrast,  the  prevalence  of  Chlamydia  pneumonia 
seropositivity  was  similar  in  patients  with  and  without 
CAD (62% versus 59%) (Momiyama et al., 2004).  
  On  the  other  hand,  coinfection  of  Mycoplasma 
pneumonia  and  Chlamydia  pneumonia  might  occur  in 
patients and may be an important cofactor for CAD, In 
the study conducted by Momiyama et al. (2004)
 it was 
found that among patients with Chlamydia pneumonia 
seropositivity,  Mycoplasma  pneumonia  seropositivity 
was more prevalent in patients with CAD than without 
CAD (17% versus 5%, p<0.01), whereas among patients 
without Chlamydia pneumonia, Mycoplasma pneumonia 
seropositivity did not differ between patients with and 
without  CAD  (9%  versus  6%).  The  study  found  that 
Mycoplasma  pneumonia  seropositivity  was  associated 
with CAD only in patients with Chlamydia pneumonia 
seropositivity  (odds  ratio  =  5.1,  95%  CI  =  1.8-14.9). 
Thus,  the  study  was  suggested  that  coinfection  by 
Mycoplasma pneumonia and Chlamydia pneumonia may 
be an important cofactor for CAD.Therefore, the risk of 
coinfection for IHD and MI, need to be determine. 
  It should be take in consideration that several case 
reports  described  an  association  between  cerebral 
ischemia  and  Mycoplasma  pneumonia  infections 
(Nakahata et al., 1983; Dowd et al., 1987; Tanir et al., 
2006). But Grau and his colleagues, on the other hand, 
had  not  detect  any  association  between  Mycoplasma 
pneumonia  infection  and  cerebrovascular  ischemia 
(Grau et al., 1995). Higuchi and his colleagues suggests 
that  the  association  of  Mycoplasma  pneumoniae  and 
Chlamydia  pneumoniae  may  increase  the  virulence  of 
these  microorganisms,  favoring  proliferation,  plaque 
inflammation and possibly plaque rupture. Mycoplasmas 
were  present  mainly  in  the  lipid  core  of  the  ruptured 
thrombosed  plaque.  Vulnerable  atheromas  are  rich  in 
cholesterol and may favor the growth of mycoplasmas, 
since the organisms require cholesterol or related sterols 
for growth (Higuchi et al., 2000; Brown et al., 2010). 
However, recent study in India found that there was no 
direct  evidence  of  the  involvement  of  Mycoplasma 
pneumonia,  Chlamydia  pneumonia  and  other  infective 
agents  and  viruses  in  CAD.  The  study  suggests  It  is 
possible that such infections produce an indirect adverse 
effect on the lipid profile (Padmavati et al., 2012).  
  In  this  study,  we  assessed  the  IgG  antibodies  to 
Mycoplasma pneumonia infection by ELISA technique; 
as  detection  of  specific  antibody  by  this  assay  is  a 
reliable and useful method for diagnosis of Mycoplasma 
pneumonia respiratory disease in human (Cassell et al., 
1996),  it  was  found  the  method  offers  several  major 
advantages  over  other  antibody  detection  methods: 
objectivity,  immunoglobulin  class  and  subclass 
specificity and increased sensitivity (Cassell et al., 1996) 
Specific antibodies of IgG have been detected by ELISA 
in patients older than 40 years and often have 56% of cases 
response  only,  whereas  children  and  teenagers  respond 
predominantly with IgM antibodies (Cassell et al., 1996), 
In our study the mean age of the patients in case and 
control  groups  was  62.54±11.19  and  64.68±13.65 
respectively, with no significant statistic difference for 
age between the groups (p = 0.26) and this will reveal 
the detection of IgG antibodies to the patients at older 
age  and  confirm  the  risk  of  association  of  the 
Mycoplasma  pneumonia  infection  in  patients  for  MI. 
The present study was matched with the result reported 
by other studies that the association between IHD and 
Mycoplasma  pneumonia  independent  of  the  role  of 
several  conventional  risk  factors;  wither  the 
Mycoplasma  pneumonia  infection  may  have  alone 
and/or cofactor effects with conventional risk factors, in 
patients with IHD and MI who has these conventional 
risk factors will need further studies to be undertaken. 
5. CONCLUSION 
  Our  results  showed  that  Mycoplasm  pneumoniae 
infection  is  a  risk  factor  for  IHD.  This  what  is 
apparently the first study performed for Mycoplasma 
pneumoniae  in  association  with  IHD  in  Saudi 
Arabia. Further work study is needed to evalute the risk of 
coinfection  by  Mycoplasma  pneumoniae  and  Chlamydia 
pneumonia. Furthermore, evalution the effects of the risk of 
these infection and conventional risk factors for IHD in this 
country should be determined. 
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